US 11691974
3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors
granted A61KA61K31/497A61P
Quick answer
US patent 11691974 (3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors) held by Medshine Discovery Inc. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/497, A61P, A61P35/00, A61P35/02